Edmp Inc. Sells 281 Shares of Cardinal Health, Inc. $CAH

Edmp Inc. lowered its stake in Cardinal Health, Inc. (NYSE:CAH) by 2.6% in the 2nd quarter, HoldingsChannel reports. The fund owned 10,331 shares of the company’s stock after selling 281 shares during the period. Cardinal Health accounts for approximately 1.5% of Edmp Inc.’s holdings, making the stock its 25th largest holding. Edmp Inc.’s holdings in Cardinal Health were worth $1,736,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Greykasell Wealth Strategies Inc. purchased a new position in Cardinal Health in the first quarter worth about $26,000. Jones Financial Companies Lllp grew its position in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares in the last quarter. GW&K Investment Management LLC grew its position in Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock worth $37,000 after acquiring an additional 144 shares in the last quarter. Garde Capital Inc. purchased a new position in Cardinal Health in the first quarter worth about $52,000. Finally, Zions Bancorporation National Association UT purchased a new position in Cardinal Health in the first quarter worth about $52,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CAH. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. UBS Group restated a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Evercore ISI dropped their target price on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Finally, Robert W. Baird boosted their target price on Cardinal Health from $197.00 to $203.00 and gave the company an “outperform” rating in a research report on Wednesday, August 13th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $166.00.

Cardinal Health Stock Down 1.7%

Shares of NYSE:CAH opened at $154.26 on Tuesday. The company has a market capitalization of $36.65 billion, a price-to-earnings ratio of 23.92, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 52 week low of $106.98 and a 52 week high of $168.44. The firm has a 50 day moving average of $152.00 and a 200 day moving average of $151.43.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio is presently 31.63%.

Insider Buying and Selling at Cardinal Health

In other news, insider Ola M. Snow sold 28,151 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jessica L. Mayer sold 38,078 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the transaction, the insider directly owned 48,457 shares in the company, valued at approximately $7,211,370.74. The trade was a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 271,676 shares of company stock valued at $40,489,525. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.